Tharimmune, Inc. (THAR) Dividend History

Tharimmune, Inc. (THAR) is a biotechnology company focused on developing innovative diagnostic and therapeutic solutions for immune-related diseases. Utilizing advanced immunoassay technologies, Tharimmune aims to improve disease detection, monitor immune responses, and develop targeted treatments, primarily serving the healthcare and biotech sectors.

1200 Route 22 East, Bridgewater, NJ, 08807
Phone: 302-743-2995
Website: https://www.hillstreambio.com

Dividend History

Tharimmune, Inc. currently does not pay dividends

Company News

These Were the 5 Top-Performing Stocks in the Nasdaq Composite in August 2025

Five Nasdaq-listed stocks significantly outperformed the index in August, with gains ranging from 188% to 378%, driven by factors like drug development progress, FDA approvals, and strategic partnerships.

The Motley Fool

Featured Companies: CGTX EQ IPDN
Stock Market Today: Dow, S&P 500 Futures Tumble As Jobless Claims Increase— Walmart, Intuit, Ross Stores Earnings In Focus (UPDATED)

U.S. stock futures were slightly lower as the Jackson Hole Economic Symposium begins, with focus on Federal Reserve Chair Jerome Powell's upcoming speech and key corporate earnings reports from Walmart, Intuit, and Ross Stores.

Benzinga

Featured Companies: COTY INTU NDSN ROST WMT
Tharimmune (THAR) Up on Positive Data From Pipeline Candidate

Tharimmune (THAR) announces positive data from a phase I study on TH104 and the development timeline in chronic pruritis in primary biliary cholangitis indication.

Zacks Investment Research

Featured Companies: ACAD DVAX LGND

Page data last updated 09/07/2025 04:03:23 UTC